Maya A. van Rossum
Leiden University Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maya A. van Rossum.
European Archives of Oto-rhino-laryngology | 2009
Lisette van der Molen; Maya A. van Rossum; Lori M. Burkhead; Ludi E. Smeele; Frans J. M. Hilgers
Organ preservation with radiotherapy and concomitant chemotherapy has become an accepted treatment modality in advanced head and neck cancer. Unfortunately, organ preservation is not synonymous with function preservation. The aim of this review was to systematically assess the effects of the disease and chemoradiotherapy (CRT) on functions such as swallowing, mouth opening, nutrition, pain and quality of life in patients with head and neck cancer. Another aim was to search for (evidence-based) techniques or strategies known to alleviate or rehabilitate the loss of function(s) associated with CRT. Two databases were searched (time period, January 1997 to August 2007) for the terms head and neck cancer, chemotherapy or cisplatin and radiotherapy, and the functional outcomes swallowing, trismus, nutrition, pain and quality of life or a variation of those words. In total, 15 relevant articles were identified that met the inclusion criteria. The majority of the studies that met the criteria focused on the outcomes swallowing, quality of life, and nutrition. Two studies reported on the outcome pain, but no paper reported on the outcome trismus. Only two papers mentioned rehabilitation options, but specific information was lacking. Further long-term prospective research is essential, not only to determine the function impairment caused by the tumor and CRT, but also to assess the effects of known and newly developed rehabilitation measures. Therefore, in September 2006, the Netherlands Cancer Institute started a randomised clinical trial (RCT): Prevention of trismus, swallowing and speech problems in patients treated with chemoradiotherapy for advanced head and neck cancer. This systematic review was carried out to collect the baseline information for the future outcomes of this RCT.
Archives of Otolaryngology-head & Neck Surgery | 2008
Elisabeth V. Sjögren; Maya A. van Rossum; Ton P. M. Langeveld; Marika S. Voerman; Vivienne A. H. van de Kamp; Mark O. W. Friebel; Ron Wolterbeek; Robert J. Baatenburg de Jong
OBJECTIVE To compare voice quality after radiotherapy or endoscopic laser surgery in patients with similar T1a midcord glottic carcinomas according to a validated multidimensional protocol. DESIGN Retrospective cohort study. SETTING University cancer referral center. PATIENTS Two cohorts of consecutive patients willing to participate after treatment for primary T1a midcord glottic carcinoma with laser surgery (18 of 23 eligible) or radiotherapy (16 of 18 eligible). MAIN OUTCOME MEASURES Posttreatment voice quality was evaluated according to a multidimensional voice protocol based on validated European Laryngological Society recommendations, including perceptual, acoustic, aerodynamic, and stroboscopic analyses, together with patient self-assessment using the Voice Handicap Index. RESULTS Approximately half of the patients had mild to moderate voice dysfunction in the perceptual analysis (53% [8 of 15] in the radiotherapy group and 61% [11 of 18] in the laser surgery group) and on the Voice Handicap Index (44% [7 of 16] in the radiotherapy group and 56% [10 of 18] in the laser surgery group). The voice profile in the laser surgery group was mainly breathy; in the radiotherapy group, it was equally breathy and rough, with a trend for more jitter in the acoustic analysis. There was no statistical difference in the severity of voice dysfunction between the groups in any of the variables. CONCLUSIONS Endoscopic laser surgery offers overall voice quality equivalent to that of radiotherapy for patients with T1a midcord glottic carcinoma, although specific voice profiles may ultimately be different for the 2 modalities. We believe that endoscopic laser surgery is the preferred treatment in these patients because it provides oncologic control similar to that of radiotherapy and the additional benefits of lower costs, shorter treatment time, and the possibility of successive procedures.
Radiotherapy and Oncology | 2013
Lisette van der Molen; Wilma D. Heemsbergen; Rianne de Jong; Maya A. van Rossum; Ludi E. Smeele; Coen R. N. Rasch; Frans J. M. Hilgers
BACKGROUND AND PURPOSE Prospective assessment of dysphagia and trismus in chemo-IMRT head and neck cancer patients in relation to dose-parameters of structures involved in swallowing and mastication. MATERIAL AND METHODS Assessment of 55 patients before, 10-weeks (N=49) and 1-year post-treatment (N=37). Calculation of dose-volume parameters for swallowing (inferior (IC), middle (MC), and superior constrictors (SC)), and mastication structures (e.g. masseter). Investigation of relationships between dose-parameters and endpoints for swallowing problems (videofluoroscopy-based laryngeal Penetration-Aspiration Scale (PAS), and study-specific structured questionnaire) and limited mouth-opening (measurements and questionnaire), taking into account baseline scores. RESULTS At 10-weeks, volume of IC receiving ≥60 Gy (V60) and mean dose IC were significant predictors for PAS. One-year post-treatment, reported problems with swallowing solids were significantly related to masseter dose-parameters (mean, V20, V40 and V60) and an inverse relationship (lower dose related to a higher probability) was observed for V60 of the IC. Dose-parameters of masseter and pterygoid muscles were significant predictors of trismus at 10-weeks (mean, V20, and V40). At 1-year, dose-parameters of all mastication structures were strong predictors for subjective mouth-opening problems (mean, max, V20, V40, and V60). CONCLUSIONS Dose-effect relationships exist for dysphagia and trismus. Therefore treatment plans should be optimized to avoid these side effects.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2012
Yda van Loon; Elisabeth V. Sjögren; Ton P. M. Langeveld; Rob J. Baatenburg de Jong; Jan W. Schoones; Maya A. van Rossum
Early glottic carcinoma is treated with laser surgery or radiotherapy, but which treatment has better functional outcomes is unclear. This systematic review compared functional outcomes (voice, swallowing, quality of life [QOL]) in more extended T1a and limited T2 tumors (1) between treatments and (2) between greater and lesser laser resections.
Annals of Otology, Rhinology, and Laryngology | 2001
Ton P. M. Langeveld; Frans Luteijn; Harm A. Drost; Maya A. van Rossum; Robert J. Baatenburg de Jong
Adductor spasmodic dysphonia (AdSD) is a controversial and enigmatic voice disorder. It is generally accepted that it has a neurologic, although undetermined, cause, and it is accompanied by much psychological and physical distress. In this prospective study, standardized psychometric tests were used to assess the personality characteristics and psychological and somatic well-being of 46 patients with AdSD. Moreover, the effect of botulinum toxin (Botox) treatment on their well-being was evaluated. No significant differences could be detected between patients and a representative norm group concerning 7 personality characteristics. Nevertheless, before treatment, there were significantly more psychological and somatic complaints. After establishment of a normal to near-normal voice with Botox injections, these complaints were reduced to normal levels — a finding suggesting these phenomena to be secondary to the voice disorder. These findings, and the normal personality characteristics, do not support a psychogenic cause of AdSD.
Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2009
Elisabeth V. Sjögren; Maya A. van Rossum; Ton P. M. Langeveld; Marika S. Voerman; Vivienne A. H. van de Kamp; Robert J. Baatenburg de Jong
Can a “typical” voice in terms of auditory perception be defined after type I or II chordectomy? Do other parameters in a multidimensional voice protocol correlate to this perceptual profile?
Dysphagia | 2011
Lisette van der Molen; Maya A. van Rossum; Lori M. Burkhead; Ludi E. Smeele; Coen R. N. Rasch; Frans J. M. Hilgers
BMC Ear, Nose and Throat Disorders | 2009
Lisette van der Molen; Maya A. van Rossum; Annemieke H. Ackerstaff; Ludi E. Smeele; Coen R. N. Rasch; Frans J. M. Hilgers
European Archives of Oto-rhino-laryngology | 2010
Irene Jacobi; Lisette van der Molen; Hermelinde Huiskens; Maya A. van Rossum; Frans J. M. Hilgers
Annals of Otology, Rhinology, and Laryngology | 2001
Ton P. M. Langeveld; Edgar H. Houtman; Jeroen J. Briaire; Maya A. van Rossum; A. H. Zwinderman; Robert J. Baatenburg de Jong